Pavla Táborská

The WNT/β-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro

Dmitry Stakheev, Pavla Táborská, Zuzana Střížová et al. · Scientific Reports · 2019 · 66 citations · Full text

Medicine, Oncology, Pharmacology +17

The paratumoral immune cell signature reveals the potential for the implementation of immunotherapy in esophageal carcinoma patients

Zuzana Střížová, Martin Snajdauf, Dmitry Stakheev et al. · Journal of Cancer Research and Clinical Oncology · 2020 · 22 citations · Full text

Medicine, Immunology, Oncology +14

NK and T cells with a cytotoxic/migratory phenotype accumulate in peritumoral tissue of patients with clear cell renal carcinoma

Zuzana Střížová, Pavla Táborská, Dmitry Stakheev et al. · Urologic Oncology Seminars and Original Investigations · 2019 · 20 citations

Medicine, Immunology, Oncology +12

Simultaneous in vitro generation of human CD34+-derived dendritic cells and mast cells from non-mobilized peripheral blood mononuclear cells

Pavla Táborská, Jiřina Bartůňková, Daniel Smrž · Journal of Immunological Methods · 2018 · 18 citations

Life Sciences, Cell Biology, Immunology +15

SARS‐CoV‐2 spike glycoprotein‐reactive T cells can be readily expanded from COVID‐19 vaccinated donors

Pavla Táborská, Jan Lašťovička, Dmitry Stakheev et al. · Immunity Inflammation and Disease · 2021 · 16 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17